Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8483
-0.0217 (-2.49%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Biofrontera Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$2.75
Upside
+224.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $7 → $2.75 | Strong Buy | Maintains | $7 → $2.75 | +224.18% | May 19, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +725.18% | Nov 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +725.18% | Aug 16, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +2,021.89% | Aug 31, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $140 → $18 | Strong Buy | Maintains | $140 → $18 | +2,021.89% | Jul 5, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +16,403.60% | May 15, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +16,403.60% | Mar 9, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $220 → $140 | Strong Buy | Reiterates | $220 → $140 | +16,403.60% | Jan 31, 2023 |
| Benchmark | Benchmark | Strong Buy Initiates $220 | Strong Buy | Initiates | $220 | +25,834.22% | Dec 15, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +47,053.13% | Nov 24, 2021 |